These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 36178367)

  • 1. RNA modifications in aging-associated cardiovascular diseases.
    Yang X; Gokulnath P; Lehmann HI; Hou Z; Yang S; You L; Zhang G; Xing Y; Lei J; Li G; Guo S; Shang H
    Aging (Albany NY); 2022 Sep; 14(19):8110-8136. PubMed ID: 36178367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA modifications in cardiovascular diseases, the potential therapeutic targets.
    Wu Y; Zhan S; Xu Y; Gao X
    Life Sci; 2021 Aug; 278():119565. PubMed ID: 33965380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases.
    Komal S; Zhang LR; Han SN
    Biomed Pharmacother; 2021 May; 137():111376. PubMed ID: 33588266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure.
    Woudenberg T; Kruyt ND; Quax PHA; Nossent AY
    Curr Heart Fail Rep; 2022 Oct; 19(5):255-266. PubMed ID: 35876969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases.
    Li M; Duan L; Li Y; Liu B
    Life Sci; 2019 Sep; 233():116440. PubMed ID: 31047893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA in cardiac aging and disease.
    Lozano-Vidal N; Bink DI; Boon RA
    J Mol Cell Biol; 2019 Oct; 11(10):860-867. PubMed ID: 31152659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncoding RNAs in age-related cardiovascular diseases.
    Jusic A; Thomas PB; Wettinger SB; Dogan S; Farrugia R; Gaetano C; Tuna BG; Pinet F; Robinson EL; Tual-Chalot S; Stellos K; Devaux Y;
    Ageing Res Rev; 2022 May; 77():101610. PubMed ID: 35338919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory long noncoding RNAs (circulatory-LNC-RNAs) as novel biomarkers and therapeutic targets in cardiovascular diseases: Implications for cardiovascular diseases complications.
    Emami Meybodi SM; Soleimani N; Yari A; Javadifar A; Tollabi M; Karimi B; Emami Meybodi M; Seyedhossaini S; Brouki Milan P; Dehghani Firoozabadi A
    Int J Biol Macromol; 2023 Jan; 225():1049-1071. PubMed ID: 36414082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases.
    Greco S; Gaetano C; Martelli F
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-Adenosine Methylation (m
    Chen YS; Ouyang XP; Yu XH; Novák P; Zhou L; He PP; Yin K
    J Cardiovasc Transl Res; 2021 Oct; 14(5):857-872. PubMed ID: 33630241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.
    Kumari R; Ranjan P; Suleiman ZG; Goswami SK; Li J; Prasad R; Verma SK
    Cardiovasc Res; 2022 Jun; 118(7):1680-1692. PubMed ID: 33956076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNA and their potential role in cardiovascular diseases.
    Samra M; Srivastava K
    Gene; 2023 Jan; 851():147011. PubMed ID: 36326502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease.
    Prestes PR; Maier MC; Woods BA; Charchar FJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and roles of RNA modifications in aging-related diseases.
    Jiapaer Z; Su D; Hua L; Lehmann HI; Gokulnath P; Vulugundam G; Song S; Zhang L; Gong Y; Li G
    Aging Cell; 2022 Jul; 21(7):e13657. PubMed ID: 35718942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epitranscriptome of long noncoding RNAs in metabolic diseases.
    Yin L; Zhu X; Novák P; Zhou L; Gao L; Yang M; Zhao G; Yin K
    Clin Chim Acta; 2021 Apr; 515():80-89. PubMed ID: 33422492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interplay within the epitranscriptome: Reality or fiction?
    Worpenberg L; Paolantoni C; Roignant JY
    Bioessays; 2022 Feb; 44(2):e2100174. PubMed ID: 34873719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Long Non-Coding RNAs in Cardiovascular Diseases.
    Le LTT; Nhu CXT
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epitranscriptome: RNA modifications in vascular remodelling.
    Nossent AY
    Atherosclerosis; 2023 Jun; 374():24-33. PubMed ID: 36400603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Peng Y; Wang Z; Li B; Tan W; Zou J; Li Y; Yoshida S; Zhou Y
    Exp Eye Res; 2022 Jul; 220():109114. PubMed ID: 35584758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.